ACM
BIIB icon

AlphaCrest Capital Management’s Biogen BIIB Stock Holding History

AlphaCrest Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,312
Closed -$675K – 1273
2022
Q2 		$675K Sell
3,312
-8,355
-72% -$1.71M 0.03% 846
2022
Q1 		$2.46M Sell
11,667
-5,784
-33% -$1.26M 0.14% 180
2021
Q4 		$4.19M Buy
17,451
+9,399
+117% +$2.42M 0.16% 132
2021
Q3 		$2.28M Sell
8,052
-1,377
-15% -$451K 0.12% 240
2021
Q2 		$3.27M Sell
9,429
-1,222
-11% -$370K 0.14% 196
2021
Q1 		$2.98M Buy
10,651
+3,305
+45% +$891K 0.17% 148
2020
Q4 		$1.8M Buy
+7,346
New +$1.9M 0.15% 162
2020
Q3 		– Sell
-8,651
Closed -$2.31M – 1089
2020
Q2 		$2.31M Buy
8,651
+5,718
+195% +$1.72M 0.39% 34
2020
Q1 		$928K Sell
2,933
-7,099
-71% -$2.15M 0.11% 310
2019
Q4 		$2.98M Sell
10,032
-5,275
-34% -$1.46M 0.24% 66
2019
Q3 		$3.56M Buy
15,307
+8,869
+138% +$2.07M 0.22% 73
2019
Q2 		$1.51M Sell
6,438
-540
-8% -$125K 0.13% 231
2019
Q1 		$1.65M Buy
6,978
+5,552
+389% +$1.75M 0.25% 75
2018
Q4 		$429K Buy
+1,426
New +$455K 0.13% 308

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AlphaCrest Capital Management's BIIB Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 3,312 shares — an estimated $675K sold.

AlphaCrest Capital Management first reported a position in BIIB in Q4 2018 and held it in 14 quarters. The position peaked at $4.19M in Q4 2021. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 3,312 Biogen shares in Q3 2022, an estimated $675K.
  • AlphaCrest Capital Management first reported a position in Biogen in Q4 2018 and held it in 14 quarters.
  • AlphaCrest Capital Management's Biogen position peaked at $4.19M in Q4 2021.
  • 987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.